Background: Constipation is a common disorder in children. Objective: The objective of this study is to assess the beneficial effects of a daily supplementation with Orafti V R inulin-type fructans in 2-5 year old constipated children. Methods: Double-blind, randomised, placebo-controlled parallel group trial where constipated children received two doses of 2 g Orafti V R inulin-type fructans (OF:IN) or placebo (maltodextrin) for 6 weeks. Primary outcome was stool consistency. Secondary outcomes were stool frequency and gastrointestinal symptoms. Results: Twenty-two children were included, 17 completed the study protocol (nine and eight for the control and the OF:IN group, respectively). Results showed that Orafti V R inulin-type fructans supplemented children had softer stools (p ¼ .003). The longitudinal analysis showed no significant changes in controls, whereas supplemented children increased their stool consistency from 2.2 to 2.6 on the modified Bristol scale for children (five items instead of seven) (p ¼ .040). Conclusions: Prebiotic inulin-type fructans supplementation improves stool consistency in constipated 2-5-year old children.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.